Zhendong Pharmaceutical announced that the company previously disclosed that it intends to transfer 53.985% of Guangdong Longchuangji Pharmaceutical Co., Ltd., and the original agreement agreed on a one-time sale. The company approved the change plan after review and approval by the board of directors on October 26, 2026. It is proposed to be divided into three deliveries: after the product has been verified and produced in three batches and passed the GMP compliance inspection, 20% of the total price is paid and 10.7970% of the shares are transferred; 70% is paid after obtaining the “Drug Registration Certificate”; and 10% after delivery of technical materials.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.